Video Experimental Relacionado
Updated: Feb 26, 2026
10:51
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
13.2K
Un par activador-bloqueador proporciona un interruptor de encendido y apagado controlable para un mutante del sitio
Vandana Lamba1, Filip Yabukarski1, Daniel Herschlag1
1Department of Biochemistry, ‡Department of Chemistry, §Department of Chemical Engineering, and ∥Stanford ChEM-H, Stanford University , Stanford, California 94305, United States.
Journal of the American Chemical Society
|July 19, 2017
Resumen
Los investigadores desarrollaron un nuevo método para controlar la actividad de la enzima utilizando dos pequeñas moléculas: una para activar y otra para bloquear la enzima. Este enfoque ofrece un rango dinámico amplio y controlable para la regulación enzimática, con aplicaciones potenciales en bioingeniería y terapéutica.
Área de la Ciencia:
- La bioquímica
- Biología molecular
- La bioingeniería
Sus antecedentes:
- El control de la actividad enzimática es crucial para los procesos biológicos y las aplicaciones terapéuticas.
- Las estrategias moleculares existentes para el control de enzimas tienen limitaciones en la generalización y el rango dinámico.
Objetivo del estudio:
- Desarrollar un método novedoso y ampliamente aplicable para controlar la actividad enzimática utilizando pequeñas moléculas.
- Demostrar un mecanismo de control preciso para la catálisis enzimática a través de la activación y el bloqueo de moléculas.
Principales métodos:
- Diseñado un bolsillo cerca del sitio activo de la isomerasa de cetosteroides (KSI).
- Se utilizan pequeñas moléculas como activadores y bloqueadores para modular la actividad enzimática.
- Evaluar la eficiencia y el rango dinámico del mecanismo de control de moléculas pequeñas.
Principales resultados:
- Se ha demostrado que el rescate de bases es eficiente y saturable utilizando un activador de molécula pequeña.
- Mostró una inhibición efectiva de la actividad enzimática por una pequeña molécula de bloqueador que carece de capacidad de base general.
- Se estableció un amplio rango dinámico controlable para la regulación de la actividad enzimática.
Conclusiones:
- Las moléculas pequeñas pueden participar directamente y bloquear la catálisis enzimática, ofreciendo un control preciso.
- Este enfoque es potencialmente aplicable a una amplia gama de enzimas.
- El método apoya la ingeniería y la detección de activadores y bloqueadores potentes para aplicaciones terapéuticas y de bioingeniería.
Videos de Conceptos Relacionados
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.9K
01:08Allosteric Regulation
63.8K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
63.8K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
01:30Enzyme Inhibition
93.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
93.4K
01:29The Two-State Receptor Model
3.3K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.3K
02:34Enzymes
95.9K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
95.9K